ofloxacin has been researched along with Cholangitis in 7 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical effect of Levofloxacin and Ceftriaxone in patients with acute cholangitis showed no significant differences." | 9.10 | [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis]. ( Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D, 2003) |
| "The clinical effect of Levofloxacin and Ceftriaxone in patients with acute cholangitis showed no significant differences." | 5.10 | [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis]. ( Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D, 2003) |
| "Thirteen hospitalized patients with various infections, five with typhoid fever, two with gastroenteritis, four with respiratory tract infection and two with biliary tract infection, were treated with ofloxacin at a daily dosage ranging between 600 and 900 mg orally." | 5.06 | Clinical experience with ofloxacin (DL 8280) in the therapy of various infections: preliminary report. ( Altucci, P; Briante, V; Cristiano, P; Leonessa, V; Morelli, G; Paradisi, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, WJ | 1 |
| Wu, ZR | 1 |
| Yang, Q | 1 |
| Hu, HJ | 1 |
| Wang, JK | 1 |
| Shi, YJ | 1 |
| Li, FY | 1 |
| Cheng, NS | 1 |
| Kiesslich, R | 1 |
| Will, D | 1 |
| Hahn, M | 1 |
| Nafe, B | 1 |
| Genitsariotis, R | 1 |
| Mäurer, M | 1 |
| Jung, M | 1 |
| Saenko, VF | 1 |
| Viktorov, AP | 1 |
| Golopykho, LI | 1 |
| Nichitaĭlo, ME | 1 |
| Gorshevikova, EV | 1 |
| Karachalios, GN | 1 |
| Nasiopoulou, DD | 1 |
| Bourlinou, PK | 1 |
| Reppa, A | 1 |
| Tanimura, H | 1 |
| Ohnishi, H | 1 |
| Okamura, T | 1 |
| Uenishi, M | 1 |
| Ichimiya, G | 1 |
| Kobayashi, Y | 1 |
| Aoki, Y | 1 |
| Oka, S | 1 |
| Yamamoto, S | 1 |
| Shimada, K | 1 |
| Mizuno, A | 1 |
| Suzuki, T | 1 |
| Taniguchi, M | 1 |
| Yura, J | 1 |
| Shinagawa, N | 1 |
| Ishikawa, S | 1 |
| Mashita, K | 1 |
| Suzui, K | 1 |
| Ishikawa, M | 1 |
| Ishihara, H | 1 |
| Cristiano, P | 1 |
| Leonessa, V | 1 |
| Morelli, G | 1 |
| Briante, V | 1 |
| Paradisi, F | 1 |
| Altucci, P | 1 |
3 trials available for ofloxacin and Cholangitis
| Article | Year |
|---|---|
[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bact | 2003 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escheric | 1996 |
Clinical experience with ofloxacin (DL 8280) in the therapy of various infections: preliminary report.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cholangitis; Clinical Trials a | 1986 |
4 other studies available for ofloxacin and Cholangitis
| Article | Year |
|---|---|
Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Chlorhexidine; Cholangitis; Chronic Disease; Collagen Ty | 2020 |
[A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
Topics: Adult; Anti-Infective Agents; Biliary Fistula; Cefazolin; Cephalosporins; Cholangitis; Drug Evaluati | 1995 |
[Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
Topics: Adult; Aged; Bile; Cholangitis; Cholecystitis; Drug Evaluation; Female; Gallbladder; Humans; Levoflo | 1992 |
[Penetration of levofloxacin in bile].
Topics: Aged; Bile; Cholangitis; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin | 1992 |